News
-
-
COMMUNIQUÉ DE PRESSE
New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details -
-
-
COMMUNIQUÉ DE PRESSE
Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Jaguar Health, Inc. announces issuance of new patent for crofelemer to treat rare diseases like SBS and MVID, enhancing IP protection. Independent studies supported in US, EU, and MENA regions -
-
-
COMMUNIQUÉ DE PRESSE
Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award
Jaguar Health announces Eduardo Zimmer as 2024 Blas Frangione Early Career Achievement Award recipient for work with Magdalena Biosciences on plant-based mental health medicines -
-